Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12029777
Serine proteinase inhibitors: Serp-1 and Serp-1 RCL-derived peptides effect on microbiome composition and uses thereof
granted -
US 12029788
Methods for increasing lean body mass with an exercise regimen and a GDF8 inhibitor that is an anti-GDF8 antibody
granted -
US 12024509
Therapeutic compounds as inhibitors of the orexin-1 receptor
granted -
US 12018259
Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors
granted -
US 12018027
Macrocyclic derivatives acting as XIa factor inhibitor
granted -
US 12018017
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted -
US 12018057
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 12016835
Neprilysin inhibitors
granted -
US 12016860
Combination therapies with Cbl-b inhibitor compounds
granted -
US 12018043
CD73 inhibitors
granted -
US 12012467
Small molecule DCN1 inhibitors and therapeutic methods using the same
granted -
US 12006355
Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)
granted -
US 12005127
DNA-PK inhibitors
granted -
US 11999747
Furoquinolinediones as inhibitors of TDP2
granted -
US 11999753
Tetrahydropyridopyrimidine pan-KRas inhibitors
granted -
AU 2022390453
NOVEL HETEROARYL-UREA COMPOUNDS AS KV7.2 INHIBITORS
granted -
US 11992480
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
granted -
US 11993603
Preparation for 6-amino-1H-pyrazolo[3,4-d]pyrimidine-based JAK kinase inhibitor and application thereof
granted -
US 11993594
IRAK inhibitors and method for making and using
granted -
US 11980633
Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
granted -
US 11969435
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
granted -
US 11964989
KRas G12D inhibitors
granted -
US 11963958
RET inhibitor for use in treating cancer having a RET alteration
granted -
US 11963959
Inhibitors for coronavirus
granted